Myer predicts return to profit in blow to Solomon Lew s campaign smh.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from smh.com.au Daily Mail and Mail on Sunday newspapers.
Image source: Getty Images
An ASX share that only listed a few weeks ago is being ignored by investors, even though next month’s reporting season could light a fire under it.
That’s according to Wilson Asset Management portfolio managers Matthew Haupt, Catriona Burns and Oscar Oberg, who reckon the pathology services provider has bright long-term prospects.
“
Australian Clinical Labs Ltd (ASX: ACL) continues to benefit from record levels of testing due to the coronavirus, which have extended further given the spread of the more infectious Delta variant,” they wrote in a memo to clients.
“The company has 86 accredited laboratories and services in approximately 90 public and private hospitals.”
Why Telstra (ASX:TLS) shares could be a buy before reporting season
Why Telstra (ASX:TLS) shares could be a buy before reporting season
Shareholders have shed many tears for the telco monolith in the past 5 years, but this year has been brighter. Can the company keep it up?
Senior journalist at The Motley Fool
Tony Yoo is a senior journalist at The Motley Fool Australia. He formerly wrote for Yahoo Finance, Business Insider and Guardian Australia. Please send story tips to tony.yoo(at)foolcontractors.com. Tony s stock holdings are here.
Latest posts by Tony Yoo (see all)
|
Telecommunications giant
Premier Investments shareholders back Lew s new attack on Myer afr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from afr.com Daily Mail and Mail on Sunday newspapers.